Schedule 13G ownership disclosure
Enanta Pharmaceuticals Inc
Security class unavailable · CUSIP: 29251M106
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,234,383
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-16-007607
- Form type
- SC 13G
- Filer
- Apex Capital Management
- CIK
- CIK 1293585
- Filed
- Feb 10, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership